Cloud-clone
SKU:PAB120Rb51
Polyclonal Antibody to Arginase (ARG)
Polyclonal Antibody to Arginase (ARG)
Couldn't load pickup availability
Western blotting: 0.5-2µg/mL;1:300-1200
Immunohistochemistry: 5-20µg/mL;1:30-120
Immunocytochemistry: 5-20µg/mL;1:30-120
Optimal working dilutions must be determined by end user.
Product No.
PAB120Rb51
Organism Species
Oryctolagus cuniculus (Rabbit).
Source
Polyclonal antibody preparation
Host
Guinea pig
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
APC
Immunogen
RPB120Rb01-Recombinant Arginase (ARG)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a cavia polyclonal antibody raised against ARG. It has been selected for its ability to recognize ARG in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|
Magazine |
Citations |
|
PLoS One |
Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers Pubmed: 24204595 |
|
J Cereb Blood Flow Metab |
Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke PubMed: 25966956 |
|
Cancer Medicine |
Circulating CD14+HLA-DR-/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease Pubmed:27109254 |
|
Cell Mol Immunol |
Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica Pubmed:27157496 |
|
Potent but transient immunosuppression of T-cells is a general feature of erythroid progenitor cells |
|
|
Commun Biol |
Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells 34893694 |
|
Catalog No. |
Related products for research use of Oryctolagus cuniculus (Rabbit) Organism species |
Applications (RESEARCH USE ONLY!) |
|
RPB120Rb01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
|
PAB120Rb51 |
WB; IHC; ICC; IP. |
|
|
LAB120Rb71 |
WB; IHC; ICC. |
Share
